Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.58
+2.3%
$5.02
$3.42
$7.20
$255.21M1.751.58 million shs708,073 shs
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
$1.71
+0.6%
$1.81
$1.32
$2.72
$251.19M1.71192,153 shs16,498 shs
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
$1.82
$1.64
$0.98
$9.21
$60.84M0.21250,384 shs437,523 shs
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$8.15
+0.4%
$5.23
$1.73
$10.43
$253.07M3.351.08 million shs556,044 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%+10.24%-15.43%+14.09%-6.63%
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
0.00%+4.27%-3.93%+14.00%-13.64%
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
0.00%0.00%0.00%0.00%+20.53%
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
0.00%+3.49%+70.40%+291.59%+185.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.2784 of 5 stars
0.01.00.00.02.10.80.6
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
0.9985 of 5 stars
3.51.00.00.00.60.00.0
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
2.3945 of 5 stars
3.52.00.00.02.42.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
3.00
Buy$7.00309.36% Upside
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
0.00
N/AN/AN/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
3.00
Buy$26.60226.58% Upside

Current Analyst Ratings Breakdown

Latest RPHM, IMMP, ACB, and SGMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $27.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$343.29M0.75$0.62 per share7.43$7.78 per share0.59
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
N/AN/AN/AN/A$1.05 per shareN/A
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
N/AN/AN/AN/A$2.66 per shareN/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
N/AN/AN/AN/A$5.08 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$1.63M$0.1141.5910.40N/A1.32%0.13%0.10%8/6/2025 (Estimated)
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
-$28.01MN/A0.00N/AN/AN/AN/AN/A7/29/2025 (Estimated)
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
-$77.39M-$2.17N/AN/AN/AN/A-62.52%-56.36%N/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
-$45.57M-$1.76N/AN/AN/AN/A-35.21%-34.09%8/13/2025 (Estimated)

Latest RPHM, IMMP, ACB, and SGMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/18/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11$0.07-$0.04-$0.24$88.85 million$63.34 million
5/8/2025Q1 2025
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
-$0.79-$0.56+$0.23-$0.56N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
N/AN/AN/AN/AN/A
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
N/AN/AN/AN/AN/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.13
4.31
2.16
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
N/A
18.86
N/A
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
N/A
57.86
57.86
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
N/A
20.34
20.34

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
2.32%
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
90.98%
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
87.86%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
3.07%
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
17.90%
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
14.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,34056.21 million56.21 millionOptionable
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
2,021146.04 million141.56 millionOptionable
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
3033.43 million27.44 millionOptionable
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
830.68 million26.17 millionOptionable

Recent News About These Companies

SGMT Sagimet Biosciences Inc. - Seeking Alpha
Sagimet Biosciences Inc. (SGMT) - Yahoo Finance
Sagimet Biosciences Inc.
Sagimet Biosciences Analyst Ratings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.58 +0.11 (+2.35%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$4.57 -0.01 (-0.22%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Prima BioMed stock logo

Prima BioMed NASDAQ:IMMP

$1.71 +0.01 (+0.59%)
As of 07/3/2025 03:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Its LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune disease. Its lead product candidate is eftilagimod alpha (efti or IMP321) for the treatment of different types of cancers. The trials that efi is being evaluated in include TACTI-002, a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC); TACTI-003, a Phase IIb clinical trial to treat HNSCC; and INSIGHT-003, a Phase I clinical trial for the treatment of NSCLC, as well as INSIGHT-005, a Phase I/IIa clinical trial to treat solid tumors. In addition, it offers IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. The company has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc., Merck & Co., Inc., Institute of Clinical Cancer Research, Merck KGaA, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is headquartered in Sydney, Australia.

Reneo Pharmaceuticals stock logo

Reneo Pharmaceuticals NASDAQ:RPHM

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

Sagimet Biosciences stock logo

Sagimet Biosciences NASDAQ:SGMT

$8.14 +0.04 (+0.43%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$8.14 0.00 (0.00%)
As of 07/3/2025 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, a once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.